Immuneering Corporation
IMRX
$1.45
-$0.01-0.69%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 36.14M | 50.66M | 59.73M | 71.28M | 85.67M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.44M | 4.60M | 3.96M | 3.17M | 3.42M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 39.59M | 55.26M | 63.69M | 74.45M | 89.08M |
|
|
|||||
| Total Current Assets | 39.59M | 55.26M | 63.69M | 74.45M | 89.08M |
| Net Property, Plant & Equipment | 4.79M | 4.95M | 5.12M | 5.25M | 5.40M |
| Long-term Investments | 6.69M | 6.69M | 6.69M | 6.69M | 6.69M |
| Goodwill | 6.69M | 6.69M | 6.69M | 6.69M | 6.69M |
| Total Other Intangibles | 350.40K | 357.70K | 365.00K | 372.40K | 379.70K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.30M | 1.30M | 1.23M | 1.22M | 1.03M |
| Total Assets | 52.71M | 68.56M | 77.09M | 87.98M | 102.58M |
|
|
|||||
| Total Accounts Payable | 1.96M | 1.94M | 2.62M | 2.27M | 2.11M |
| Total Accrued Expenses | 4.97M | 4.59M | 3.76M | 2.58M | 5.17M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 338.40K | 324.70K | 311.50K | 298.50K | 300.10K |
| Total Finance Division Other Current Liabilities | 233.70K | 59.70K | 90.20K | 23.60K | 259.80K |
| Total Other Current Liabilities | 233.70K | 59.70K | 90.20K | 23.60K | 259.80K |
| Total Current Liabilities | 7.50M | 6.92M | 6.78M | 5.18M | 7.85M |
|
|
|||||
| Total Current Liabilities | 7.50M | 6.92M | 6.78M | 5.18M | 7.85M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.82M | 3.92M | 4.00M | 4.08M | 4.16M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.33M | 10.84M | 10.78M | 9.26M | 12.01M |
|
|
|||||
| Common Stock & APIC | 265.68M | 263.96M | 257.95M | 256.29M | 253.84M |
| Retained Earnings | -224.30M | -206.24M | -191.65M | -177.57M | -163.26M |
| Treasury Stock & Other | -- | 7.80K | -- | -1.10K | -800.00 |
| Total Common Equity | 41.39M | 57.72M | 66.31M | 78.72M | 90.58M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 41.39M | 57.72M | 66.31M | 78.72M | 90.58M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 41.39M | 57.72M | 66.31M | 78.72M | 90.58M |
|
|
|||||